🔎 Trials Near Me

Dachaigh › Colitis Ulcerative › Texas

Sgrùdaidhean clionaigeach Colitis Ulcerative ann an Texas

Tha 33 sgrùdaidhean airson Colitis Ulcerative a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
  • GI Alliance - Lubbock ( Site 0288), Lubbock
  • Caprock Gastro Research ( Site 0293), Lubbock
  • agus 3 a bharrachd
A’ fastadhÌre 3
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Novel Research - Bellaire /ID# 280925, Bellaire
  • Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
  • Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
  • agus 9 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • The Clinical Trials Network CTNX LLC, El Paso
  • Amel Med LLC, Georgetown
  • Kelsey Research Foundation, Houston
  • agus 7 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • University of Texas - Southwestern Medical Center /ID# 271835, Dallas
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

  • Southern Star Research Institute, San Antonio
A’ fastadhÌre 2
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research, Baytown
  • DHR Health Gastroenterology - Edinburg, Edinburg
  • Baylor College of Medicine, Houston
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Cedar Park
  • Xencor Investigative Site, Denton
  • Xencor Investigative Site, Garland
  • agus 8 a bharrachd
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 013, Cedar Park
  • Site 005, Garland
  • Site 002, San Antonio
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-024, Garland
  • Site US-009, Georgetown
  • Site US-030, Houston
  • agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • The University of Texas at Austin, Austin
  • DFW Clinical Trials, Carrollton
  • Victorium Clinical Research, Houston
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Cook Childrens Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Local Institution - 0103, Fort Worth
  • Texas Children's Hospital, Houston
A’ fastadhÌre 2/3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • agus 2 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Texas Digestive Disease Consultants - Cedar Park, Cedar Park
  • GI Alliance - Dallas - Gaston Avenue, Dallas
  • GI Alliance - Fort Worth, Fort Worth
  • agus 5 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • One of a Kind Clinical Research Center - Kingwood, Kingwood
  • Southern Star Research Institute, San Antonio
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Cook Children's Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Fort Worth, Fort Worth
  • GI Alliance - Garland, Garland
  • Integrity Advanced Therapeutics, Houston
  • agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • GI Alliance - Digestive Health Associates of Texas, Dallas
  • The University of Texas Health Science Center at Houston, Houston
  • GI Alliance - Mansfield, Mansfield
  • agus 4 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Lubbock - Site Number: 8400092, Lubbock
  • Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern Star Research Institute, LLC, San Antonio
  • Tyler Research Institute, LLC, Tyler
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07577856

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

  • BAMC, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT04372108

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Texas Digestive Disease Consultants, Cedar Park
  • Baylor College of Medicine, Houston
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research - Site Number: 8400144, Baytown
  • The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
  • Valley Institute of Research - Site Number: 8400004, Harlingen
  • agus 7 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • University of Texas Southwestern, Dallas
  • Baylor College of Medicine, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Amarillo Premier Research (Objective Health), Amarillo
  • Digestive Research of Central Texas (Objective Health), Waco
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06571669

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Houston Endoscopy & Research Center, Houston
  • BI Research Center, Houston
  • Brooke Army Medical center, San Antonio
  • agus 2 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • ACT-Midwest G1, Abilene
A’ fastadhÌre 2
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT05287126

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Tyler Research Institute, LLC, Tyler
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06764615

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT04751396

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Texas Children's Hospital - Baylor - PIN, Houston
A’ fastadhÌre 3
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT05442567

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Dallas
  • Mirador Therapeutics Selected Site, Garland
  • Mirador Therapeutics Selected Site, Georgetown
  • agus 5 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522

Registry and Biorepository for IBD in Central Texas

  • Dell Medical School, UT Austin, Austin
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 18 Cèit 2021 · NCT04617184

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.